Literature DB >> 25220833

Contralateral oblique view is superior to lateral view for interlaminar cervical and cervicothoracic epidural access.

Jatinder S Gill1, Moris Aner, Jyotsna V Nagda, Nagda Jyotsna, John C Keel, Thomas T Simopoulos.   

Abstract

OBJECTIVE: The purpose of this study was to compare the reliability of the lateral fluoroscopic view and several contralateral oblique (CLO) views at different angles in visualizing and accurately predicting the position of the needle tip at the point of access in the posterior cervical and cervicothoracic epidural space.
DESIGN: After the epidural space was accessed but before confirmation with contrast fluoroscopy, we prospectively obtained fluoroscopic images at eight different angles. Subsequent contrast injection confirmed epidural spread. Needle tip visualization and location of needle relative to bony landmarks were analyzed.
RESULTS: The needle tip was clearly visualized in all CLO projections in all 24 subjects. CLO view at 50 degrees and at obliquity measured on magnetic resonance imaging (MRI) images provided the most consistent needle tip location. In these views, the epidural space was accessed at or just beyond the ventral laminar margin at the ventral interlaminar line or within the proximal half of the predefined CLO area in all patients. The needle tip was poorly visualized in the lateral view and the location of the needle tip was less well defined and independent of the needle location in the anteroposterior (AP) view.
CONCLUSIONS: This study provides evidence that during cervical and cervicothoracic epidural access, the CLO view at 50 degrees and at MRI-measured obliquity is superior to the lateral view for the purpose of needle tip visualization and in providing a consistent landmark for accessing the epidural space. This article also introduces the concept of zones to describe needle position in the cervical and cervicothoracic spine in AP, lateral, and oblique views. Wiley Periodicals, Inc.

Entities:  

Keywords:  Epidural (Injection Space); Fluoroscopy

Mesh:

Year:  2014        PMID: 25220833     DOI: 10.1111/pme.12557

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  7 in total

Review 1.  [Evidence-based interventional pain medicine : Progress over the past 10 years].

Authors:  Stephan Klessinger; Martin Legat; Markus Schneider
Journal:  Schmerz       Date:  2020-04       Impact factor: 1.107

2.  Contrast Spread Technique: Evolution.

Authors:  Yakov Perper
Journal:  Pain Med       Date:  2016-02-05       Impact factor: 3.750

3.  Evaluation of Contrast Flow Patterns with Cervical Interlaminar Epidural Injection: Comparison of Midline and Paramedian Approaches.

Authors:  Byeongcheol Lee; Sang Eun Lee; Yong Han Kim; Jae Hong Park; Ki Hwa Lee; Eunsu Kang; Sehun Kim; Jaehwan Kim; Daeseok Oh
Journal:  Medicina (Kaunas)       Date:  2020-12-24       Impact factor: 2.430

4.  Contralateral and Lateral Views: Analysis of the Technical Aspects of Spinal Cord Stimulator Lead Insertion.

Authors:  Jatinder Gill; Lynn Kohan; Jamal Hasoon; Ivan Urits; Omar Viswanath; Kambiz Sadegi; Vwaire Orhurhu; Anthony C Lee; Musa M Aner; Thomas T Simopoulos
Journal:  Anesth Pain Med       Date:  2022-02-23

5.  Dural Puncture During Spinal Cord Stimulator Lead Insertion: Analysis of Practice Patterns.

Authors:  Warren A Southerland; Jamal Hasoon; Ivan Urits; Omar Viswanath; Thomas T Simopoulos; Farnad Imani; Hakimeh Karimi-Aliabadi; Musa M Aner; Lynn Kohan; Jatinder Gill
Journal:  Anesth Pain Med       Date:  2022-05-11

6.  Method to Reduce the False-Positive Rate of Loss of Resistance in the Cervical Epidural Region.

Authors:  Young Uk Kim; Doohwan Kim; Jun Young Park; Jae-Hyung Choi; Ji Hyun Kim; Heon-Yong Bae; Eun-Young Joo; Jeong Hun Suh
Journal:  Pain Res Manag       Date:  2016-03-29       Impact factor: 3.037

7.  On the Spinal Cord Injury During Attempted Cervical Interlaminar Epidural Injection of Steroids.

Authors:  Yakov Perper
Journal:  Pain Med       Date:  2019-04-01       Impact factor: 3.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.